Indian Spices Contaminated with Cancer-Causing Chemical: Hong Kong Food Regulators Issue Warning

▴ Hong Kong Food Regulators Issue Warning
Consumers are advised to remain vigilant and refrain from consuming the affected spice products until further updates and clarifications are provided by the relevant food regulatory authorities.

A shocking report from Hong Kong's Centre for Food Safety (CFS) has revealed concerning findings about the presence of cancer-causing substances in certain spice products imported from India. The report, published on April 5th, highlighted that three spice products tested positive for ethylene oxide, a pesticide known to be a Group 1 carcinogen.

The CFS, in collaboration with food regulatory authorities in Singapore, conducted tests on spice products from India and discovered elevated levels of ethylene oxide in specific brands. Notably, three spice products from prominent Indian companies MDH and Everest were found to contain levels of ethylene oxide exceeding permissible limits.

The affected spice products identified by the CFS include:
- MDH Madras Curry Powder (spice blend for Madras Curry)
- MDH Sambhar Masala (Mixed Masala Powder)
- MDH Curry Powder (Mixed Masala Powder)
- Everest Fish Curry Masala

Ethylene oxide, classified as a Group 1 carcinogen by the International Agency for Research on Cancer, poses significant health risks, particularly with prolonged exposure through food consumption. The presence of this pesticide in spice products raises serious concerns about public health and safety.

Following the test results, the CFS instructed retailers to cease the sale and remove the affected spice products from shelves to prevent further exposure to consumers. Under the Pesticide Residues in Food Regulation (Cap.132CM), food containing pesticide residue must not pose a danger or health hazard to consumers. Violations of this regulation carry substantial penalties, including fines and imprisonment upon conviction.

In response to the findings, the Singapore Food Agency (SFA) also took swift action by ordering the recall of Everest's Fish Curry Masala due to elevated levels of ethylene oxide exceeding permissible limits. The SFA directed the importer, Sp Muthiah & Sons Pte. Ltd., to initiate a recall process to remove the affected product from the market.

Ethylene oxide, although used for sterilization in certain contexts, is deemed unfit for consumption due to its carcinogenic properties. While low levels of ethylene oxide in food may not pose an immediate health risk, prolonged exposure can potentially lead to adverse health effects, including the development of cancer cells.

The SFA emphasized the importance of minimizing exposure to ethylene oxide and reiterated that its use in food products should be strictly regulated to protect public health. Both the CFS and SFA are continuing their investigations into this matter to ensure comprehensive monitoring and enforcement of food safety standards.

Consumers are advised to remain vigilant and refrain from consuming the affected spice products until further updates and clarifications are provided by the relevant food regulatory authorities. It is crucial to prioritize food safety and take necessary precautions to avoid potential health risks associated with contaminated food products.

Tags : #

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026
Handpickd Questions the Role of Science in Food with ‘Science-Less’ Newspaper CampaignSeptember 16, 2026
As Women’s Cancer Burden Rises, Integrated Care Emerges as The Next Frontier in Cancer TreatmentSeptember 16, 2026
Odia Superstar Babushaan Mohanty Inaugurates Manoj Das Library at Utkal Gaurav International SchoolSeptember 16, 2026
Yashoda Hospitals, Somajiguda Successfully Treats 10-Month-Old with Complex Heart Condition Through Staged ApproachSeptember 16, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026
Dr. Reddy's Laboratories Launches Nationwide Educational Initiative to Strengthen India's Obesity Care WorkforceSeptember 14, 2026
IIM Bodh Gaya Hosts Convergence 3.0: The Next Frontier of Healthcare SectorSeptember 14, 2026